ask="N/A"
ask_size="N/A"
average_daily_volume="319648"
bid="70.00"
bid_size="100"
book_value="9.87"
change="+1.48"
change_from_200_day_moving_average="7.89"
change_from_50_day_moving_average="6.41"
change_from_52_week_high="-9.51"
change_From_52_week_low="45.24"
change_in_percent="+1.93%"
close="78.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="4.96"
ebitda="52.83M"
eps_estimate_current_year="3.96"
eps_estimate_next_quarter="0.69"
eps_estimate_next_year="4.48"
ex_dividend_date="N/A"
float_shares="9109000"
high="78.97"
high_52_weeks="87.78"
last_trade_date="3/9/2017"
last_trade_price="78.26"
last_trade_size="6314"
last_trade_time="4:00pm"
low="76.34"
low_52_weeks="33.02"
market_capitalization="1.20B"
moving_average_200_day="70.37"
moving_average_50_day="71.85"
name="Eagle Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="85.00"
open="76.68"
pe_ratio="15.78"
peg_ratio="1.29"
percent_change_from_200_day_moving_average="+11.22%"
percent_change_from_50_day_moving_average="+8.93%"
percent_change_from_52_week_high="-10.84%"
percent_change_from_52_week_low="+137.01%"
previous_close="76.78"
price_eps_estimate_current_year="19.76"
price_eps_Estimate_next_year="17.47"
price_per_book="7.78"
price_per_sales="6.21"
revenue="189.48M"
shares_outstanding="15324000"
short_ratio="13.93"
stock_exchange="NGM"
symbol="EGRX"
volume="165410"
weeks_range_52="33.02 - 87.78"
